Skip to main content
. 2017 Dec 21;62(1):e01260-17. doi: 10.1128/AAC.01260-17

TABLE 2.

Antimicrobial susceptibility profiles of six clinical isolates, an E. coli J53A transconjugant of AMA 754 (AMA 1292), and E. coli J53A and β-lactam susceptibilities of E. coli TOP10 expressing β-lactamases and E. coli TOP10

Antibiotic MIC (mg/liter)
E. asburiae AMA 497 E. asburiae AMA 590 C. freundii AMA 754 K. pneumoniae AMA 782 E. asburiae AMA 810 C. freundii AMA 948 E. coli AMA 1292a E. coli J53A3R E. coli TOP10(pCR-BluntII-OXA-436) E. coli TOP10(pCR-BluntII-OXA-48) E. coli TOP10(pCR-BluntII-OXA-181) E. coli TOP10
Temocillin >256 >256 >256 >256 >256 >256 >256 8 >256 >256 >256 16
Piperacillin-tazobactam >64 >64 >64 >64 >64 >64 >64 2 >64 >64 >64 2
Ceftazidime >32 >32 32 >32 >32 >32 >32 0.25 0.5 1 1 0.5
Ceftazidime-avibactam 0.5 0.25 0.5 0.5 0.25 1 0.5 0.125 0.25 0.5 1 0.25
Cefotaxime 8 8 8 4 8 >16 4 ≤0.06 0.125 1 2 0.125
Cefoxitin >32 >32 >32 16 >32 >32 16 8 16 16 32 4
Aztreonam >16 >16 >16 >16 >16 >16 >16 ≤0.125 ≤0.125 0.25 0.25 ≤0.125
Meropenem 4 4 1 2 4 1 1 0.032 0.5 1 1 0.032
Imipenem 4 4 2 2 4 2 2 0.25 2 2 2 0.25
Ertapenem >4 4 4 >4 >4 4 4 ≤0.015 1 2 2 ≤0.015
Gentamicin 128 128 64 128 64 64 32 ≤0.25 NDb ND ND ND
Amikacin <1 <1 <1 <1 <1 <1 <1 <1 ND ND ND ND
Tobramycin 4 8 8 8 8 4 2 <0.5 ND ND ND ND
Ciprofloxacin 4 4 8 16 4 2 0.5 <0.015 ND ND ND ND
Tigecycline 0.5 0.5 2 1 1 0.5 0.25 0.25 ND ND ND ND
Colistin 0.5 0.5 1 0.5 0.5 1 ≤0.25 0.5 ND ND ND ND
Trimethoprim-sulfamethoxazole >16 >16 >16 >16 >16 >16 >16 >16 ND ND ND ND
a

AMA 1292 is the E. coli J53A transconjugant of AMA 754.

b

ND, not determined.